✦ LIBER ✦

Postoperative recurrence of Crohn's disease: Pathophysiology and prevention

✍ Scribed by Dr. Geert D'Haens; Paul Rutgeerts

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 944 KB
Volume: 5
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.3780050411

No coin nor oath required. For personal study only.

✦ Synopsis

Postoperative recurrence of Crohn's disease is often inevitable. Certain risk factors such as smoking, young age, and a perforating disease behavior have been identified. Patients running an enhanced risk should be treated with mesalamine or, with higher success rates, with azathioprine. An en-doscopic evaluation of the neoterminal ileum 6 to 12 months after surgery provides relevant information predicting the further clinical course and can be used as a guide to adjust medical therapy.

📜 SIMILAR VOLUMES

Management and prevention of postoperati

Management and prevention of postoperative Crohn's disease

✍ Miguel Regueiro 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

Postoperative Crohn's disease (CD) recurrence is a common occurrence after intestinal resection. Currently, the optimal management of patients who have undergone surgical resection is unknown and treatment remains subjective. Clinicians in conjunction with patients must balance the risks of recurren

Purine analog for the prevention of post

Purine analog for the prevention of postoperative recurrence of Crohn's disease: Is it really better?

✍ Julia J. Liu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 2 views

Severity of postoperative recurrence in

Severity of postoperative recurrence in crohn's disease: Correlation between endoscopic and sonographic findings

✍ Emma Calabrese; Carmelina Petruzziello; Sara Onali; Giovanna Condino; Francesca 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

Background: Crohn's disease (CD) recurrence is currently assessed by ileocolonoscopy. Small intestine contrast ultrasonography (SICUS) visualizes the small bowel lesions in CD, although its role after curative resection is undefined. We aimed to investigate the accuracy of SICUS in assessing CD recu

Faecal calprotectin or lactoferrin can i

Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease

✍ C. A. Lamb; M. K. Mohiuddin; J. Gicquel; D. Neely; F. G. Bergin; J. M. Hanson; J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

Can fecal calprotectin or lactoferrin id

Can fecal calprotectin or lactoferrin identify postoperative recurrence in Crohn's disease?

✍ Frank Seibold; Alain M. Schoepfer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

F ecal calprotectin and lactoferrin are sensitive markers of intestinal inflammation in IBD. They have been shown to correlate with clinical and endoscopic activity [1][2][3] and their prognostic value in detecting upcoming flares is increasingly being recognized. 4 Lamb et al investigated fecal cal

Validating Crohn's disease activity indi

Validating Crohn's disease activity indices for use in assessing postoperative recurrence

✍ T.D. Walters; A.H. Steinhart; C.N. Bernstein; W. Tremaine; M. McKenzie; B.G. Wol 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB 👁 1 views

## Background: The crohn's disease activity index (cdai) has been used in medical trials with scores <150 indicative of remission. its value in assessing postoperative recurrence is unknown. the objective of this study was to explore the utility of the cdai in determining the presence or absence of